Emirates Biotech, a Dubai-based company, has signed a supply contract with Swiss company Sulzer to provide equipment for a new bioplastics plant in the UAE. The plant will produce polylactic acid (PLA) from lactic acid, which is derived from renewable plant-based sources. The contract is a strategic milestone for Emirates Biotech’s Falcon PLA project, a partnership with Global Biopolymers and SS Royal Kit Emirates Investment. The equipment supplied by Sulzer will include lactide formation, purification, and polymerisation technology. Emirates Biotech’s investment in the project exceeds $90 million, and the facility will be located in the KEZAD free zone in Abu Dhabi. Construction is expected to start in the fourth quarter of this year, with the plant scheduled to become operational by early 2028. The facility will have a capacity of 80,000 tonnes/year and will be constructed in two phases. Emirates Biotech has also appointed Samsung E&A as the contractor for the PLA facility, which will integrate Sulzer’s equipment within the wider plant infrastructure. The project aims to anchor the region’s transition to sustainable materials.
Emirates Biotech inks deal with Sulzer for equipment supply contract…
